WaisMed Receives FDA Approval for NIO

September 22, 2014

WaisMed, PerSys Medical company, has received FDA approval for the NIO, a new intraosseous medical device for adults.

The NIO is a simple, automatic, intraosseous device which provides safe, quick and easy vascular access in emergency situations, when vascular access is needed for fluid and drug administration.

The NIO is designed to be easily injected into the tibia or humerus in all clinical and emergency settings. It is user-friendly and pocket-sized, includes double safety features, and doesn’t require any external power source, allowing for vascular access in a manner of seconds. The NIO is a disposable single use device with a five year shelf life.

Roee Madai, the CEO of WaisMed said, “We are extremely proud and happy to bring this product to market; this is yet another achievement in the long tradition of Persys Medical, setting standards and ultimately saving lives.”

The NIO should be available for sale on the PerSys Medical website this fall, and further updates can be found at

About WaisMed

WaisMed Ltd. has 20 years of experience in successfully designing, manufacturing and distributing intraosseous devices, including the Bone Injection Gun (B.I.G.), which is the world’s first automatic intraosseous infusion device and is sold in over 40 countries worldwide. WaisMed Ltd. holds a leading position in IO technology and is in the process of expanding its global presence and product line for applications beyond the scope of Emergency Medicine. WaisMed Ltd. is a PerSys Medical company.